Concourse Financial Group Securities’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2
Closed -$1.27K 2287
2020
Q3
$2K Hold
2
﹤0.01% 1985
2020
Q2
$2K Hold
2
﹤0.01% 1885
2020
Q1
$1K Hold
2
﹤0.01% 2001
2019
Q4
$2K Buy
+2
New +$2.17K ﹤0.01% 1867
2019
Q3
Sell
-2
Closed -$3.05K 1789
2019
Q2
$3K Hold
2
﹤0.01% 1861
2019
Q1
$4K Sell
2
-1
-33% -$1.76K ﹤0.01% 1786
2018
Q4
$3K Buy
+3
New +$4.6K ﹤0.01% 1804

Other funds holding BLUE

Concourse Financial Group Securities's BLUE Position: Q4 2020 in Review

Concourse Financial Group Securities sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 2 shares — an estimated $1.27K sold.

Concourse Financial Group Securities first reported a position in BLUE in Q4 2018 and held it in 7 quarters. The position peaked at $4K in Q1 2019. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • Concourse Financial Group Securities reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
  • Concourse Financial Group Securities sold 2 bluebird bio shares in Q4 2020, an estimated $1.27K.
  • Concourse Financial Group Securities first reported a position in bluebird bio in Q4 2018 and held it in 7 quarters.
  • Concourse Financial Group Securities's bluebird bio position peaked at $4K in Q1 2019.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on Concourse Financial Group Securities's 13F filing for Q4 2020, filed 2 Feb 2021.